1. Emami, Zahra, Shobeiri, Saeideh Sadat, Khorrami, Razia, Pordel, Safoora, Sankian, Mojtaba. 2024. Evaluation of Kynu, Defb2, Camp, and Penk Expression Levels as Psoriasis Marker in the Imiquimod-Induced Psoriasis Model. In Mediators of inflammation, 2024, 5821996. doi:10.1155/2024/5821996. https://pubmed.ncbi.nlm.nih.gov/39045230/
2. Wu, Lan-Tu-Ya, Qiao, Zhu-Hui, Tian, Jia-Bin, Hou, Su-Chun, Liu, Xiao-Ming. . The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity. In Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 29, e13405. doi:10.1111/srt.13405. https://pubmed.ncbi.nlm.nih.gov/37522491/
3. Selleri, S, Arnaboldi, F, Palazzo, M, Balsari, A, Rumio, C. . Toll-like receptor agonists regulate beta-defensin 2 release in hair follicle. In The British journal of dermatology, 156, 1172-7. doi:. https://pubmed.ncbi.nlm.nih.gov/17535220/